Preclinical research reveals that new IgM antibodies administered intranasally to fight COVID-19 more potent than commonly used ones

A nasal therapy, built upon on the application of a new engineered IgM antibody therapy for COVID-19, was more effective than commonly used IgG antibodies at neutralizing the COVID-19 virus in animal models, according to new research.

from Top Health News -- ScienceDaily https://ift.tt/2T5IMXm